Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice-Reference-Cited by-同舟云学术

Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice

Published:2010-03-05 Issue:9 Volume:70 Page:1002-1011
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Arredouani Mohamed S.,Tseng-Rogenski Stephanie S.,Hollenbeck Brent K.,Escara-Wilke June,Leander Karen R.,Defeo-Jones Deborah,Hwang Clara,Sanda Martin G.

Funder

NIH

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.21134/fullpdf

Reference42 articles.

1. Technology insight: Vaccine therapy for prostate cancer;Vieweg;Nat Clin Pract Urol,2005

2. Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination;Noguchi;Prostate,2003

3. Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells-A pilot study;Hildenbrand;Prostate,2007

4. Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: A phase I/II study;Pandha;BJU Int,2004

5. Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer;Small;J Clin Oncol,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy;Journal for ImmunoTherapy of Cancer;2024-05

2. New approaches and prospects of immunotherapy and gene therapy for prostate cancer;Journal of Translational Genetics and Genomics;2024-03-29

3. SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients;Frontiers in Immunology;2022-09-02

4. Androgen conspires with the CD8 ⁺ T cell exhaustion program and contributes to sex bias in cancer;Science Immunology;2022-07

5. Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer;Cancers;2022-01-20